Evidence map›Paper›PMID 42792081›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Antibiotic Utilization Patterns and Appropriateness of Antibiotic Prescribing in an Internal Medicine Service of a Secondary Care Hospital: A Retrospective Drug Utilization Study.

Ana Luisa Robles-Piedras, Leonardo Rosas-Villedas, Urias Bautista-Sánchez, José Roberto Medécigo-Hernández, Leonel Jeshua Vazquez-Ortiz, Elena Guadalupe Olvera-Hernández, Alejandro Chehue-Romero

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ana Luisa Robles-PiedrasAcademic Area of Pharmacy, Institute of Health Sciences, Autonomous University of the State of Hidalgo, San Agustín Tlaxiaca C.P. 42160, Hidalgo, Mexico.ORCID 0000-0002-8697-605X
Leonardo Rosas-VilledasAcademic Area of Pharmacy, Institute of Health Sciences, Autonomous University of the State of Hidalgo, San Agustín Tlaxiaca C.P. 42160, Hidalgo, Mexico.ORCID 0009-0005-8648-9429
Urias Bautista-SánchezAcademic Area of Pharmacy, Institute of Health Sciences, Autonomous University of the State of Hidalgo, San Agustín Tlaxiaca C.P. 42160, Hidalgo, Mexico.ORCID 0000-0002-1182-2179
José Roberto Medécigo-HernándezGeneral Hospital "Dra. Columba Rivera Osorio", Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico-Pachuca Highway Km. 86.5, Col. Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Pachuca de Soto C.P. 42083, Hidalgo, Mexico.
Leonel Jeshua Vazquez-OrtizAcademic Area of Pharmacy, Institute of Health Sciences, Autonomous University of the State of Hidalgo, San Agustín Tlaxiaca C.P. 42160, Hidalgo, Mexico.ORCID 0009-0007-7851-6153
Elena Guadalupe Olvera-HernándezAcademic Area of Pharmacy, Institute of Health Sciences, Autonomous University of the State of Hidalgo, San Agustín Tlaxiaca C.P. 42160, Hidalgo, Mexico.
Alejandro Chehue-RomeroAcademic Area of Pharmacy, Institute of Health Sciences, Autonomous University of the State of Hidalgo, San Agustín Tlaxiaca C.P. 42160, Hidalgo, Mexico.ORCID 0000-0003-3054-7544

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesAntimicrobial resistance poses a severe global threat, particularly in low- and middle-income countries. Hospitalized patients in internal medicine wards are vulnerable to inappropriate antibiotic exposure. This study aimed to evaluate antibiotic utilization patterns, standardize volumetric consumption, and assess the appropriateness of antibiotic prescribing against national guidelines in the Internal Medicine service of a secondary-care hospital in Mexico.

methodsA retrospective descriptive drug-utilization study based on hospital records was conducted from July 2023 to December 2024. During this period, 1127 admissions to the Internal Medicine service were recorded; 413 eligible patients who received at least one systemic antimicrobial agent were included, accounting for 769 prescription events. Antimicrobial consumption was expressed as Defined Daily Doses (DDDs) per 100 admissions according to WHO ATC/DDD methodology. A focused prescribing-appropriateness assessment was performed for the five most frequently prescribed antimicrobial agents (

resultsThe cohort had a mean age of 61.4 ± 18.2 years, and 51.3% were aged ≥65 years. Cephalosporins (30.4%) and carbapenems (16.1%) were the most frequently prescribed pharmacological classes. Ceftriaxone had the highest standardized utilization density (49.69 DDDs/100 admissions) and an 80.6% prescribing-alignment rate. Meropenem followed with 44.72 DDDs/100 admissions despite substantially fewer prescription events. The largest proportions of prescription events classified as opportunities for optimization were observed for levofloxacin (48.5%), vancomycin (41.4%), and meropenem (36.1%).

conclusionsHigh overall guideline alignment (73%) coexisted with substantial use of broad-spectrum antimicrobials. Stewardship prioritization should integrate quantitative utilization with qualitative prescribing assessment rather than interpret total DDD burden as avoidable exposure. These findings provide a baseline for targeted antimicrobial stewardship and clinical-pharmacy interventions in a resource-constrained secondary-care setting.

Indexed as

antimicrobial stewardshipappropriateness of antibiotic prescribingdrug utilization studyinappropriate prescribinginternal medicineMexicosecondary care hospital

Identifiers

PMID42792081
PMCPMC13603780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.